The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China; Department of Pathology, School & Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China.
Department of Pathology, School & Hospital of Stomatology, Wuhan University, Wuhan, Hubei, China.
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(4S):101551. doi: 10.1016/j.jormas.2023.101551. Epub 2023 Jul 4.
The present study aims to identify adenoid ameloblastoma (AdAM) from previously diagnosed cases of dentinogenic ghost cell tumor (DGCT), and gain insight to the possible relationship between AdAM and DGCT.
DGCT cases diagnosed between 2006 and 2022 were re-examined with focus on the AdAM-like features.
A total of nine patients were included. Seven patients were males and two were females. The mean age was 38.0 ± 16.0 years. Five tumors occurred in the maxilla and four in the mandible, with a remarkable predilection for the posterior regions of both jaws. Microscopically, dentinoid material deposition was present in all cases. The ghost cells were absent in two cases. Rare ghost cells (<1%) were observed in three cases, and a higher proportion of ghost cells (5%-20%) were present in the remaining four cases. All cases showed prominent AdAM-like features, including duct-like structures, whorls/morules, and cribriform architecture. According to the diagnostic criteria proposed by the 2022 WHO classification, five cases without or with rare ghost cells were reclassified as AdAM. The other four cases including a higher proportion of ghost cells consisted of a mixture of DGCT and AdAM histopathologic patterns.
Our results confirmed that the AdAM-like features had been largely overlooked in the diagnosis of DGCT at our institution in the past. Whilst a subset can now be more accurately classified as AdAM, some tumors showed overlapping morphological features between AdAM and DGCT, suggesting that the two may represent a spectrum of the same entity.
本研究旨在从先前诊断的牙源性影细胞肿瘤(DGCT)病例中识别腺样造釉细胞瘤(AdAM),并深入了解 AdAM 与 DGCT 之间的可能关系。
重新检查了 2006 年至 2022 年期间诊断的 DGCT 病例,重点关注腺样造釉细胞瘤样特征。
共纳入 9 例患者。7 例为男性,2 例为女性。平均年龄为 38.0±16.0 岁。5 例肿瘤发生在上颌骨,4 例发生在下颌骨,下颌骨后区明显偏好。显微镜下,所有病例均有牙本质样物质沉积。2 例无鬼影细胞。3 例鬼影细胞少见(<1%),4 例鬼影细胞较多(5%-20%)。所有病例均表现出明显的腺样造釉细胞瘤样特征,包括导管样结构、漩涡/珠状结构和筛状结构。根据 2022 年 WHO 分类提出的诊断标准,5 例无鬼影细胞或鬼影细胞少见的病例被重新分类为 AdAM。另外 4 例包括较多鬼影细胞的病例,包含 DGCT 和 AdAM 组织病理学模式的混合。
我们的结果证实,过去我院在诊断 DGCT 时,很大程度上忽略了腺样造釉细胞瘤样特征。虽然现在可以更准确地将一部分病例分类为 AdAM,但一些肿瘤的形态特征在 AdAM 和 DGCT 之间存在重叠,表明两者可能代表同一实体的不同表现。